查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632602

全球止血瓣膜市场：市场规模、份额及趋势分析（按类型、应用、最终用途、地区及细分市场，2025-2030 年）

Hemostasis Valve Market Size, Share & Trends Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application (Angiography, Angioplasty), By End Use, By Region and Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

止血瓣膜市场规模及趋势：

2024 年全球止血瓣膜市场规模估计为 1.846 亿美元，预计 2025 年至 2030 年期间复合年增长率为 5.8%。

心血管疾病发病率的上升、支持性法律规范、老年人口的成长以及技术进步极大地推动了市场的成长。 《2024 年世界心臟报告》强调，空气污染会加剧所有主要心血管疾病 (CVD)。 2019年，与环境空气污染相关的420万人死亡中，近70%是由于心血管问题，尤其是缺血性心臟疾病（190万人死亡）和中风（90万人死亡）。这增加了对血管造影术和血管成形术等诊断和治疗程序的需求，而止血阀对于在导管手术期间控制血流和确保患者安全至关重要。

人们对微创手术的偏好日益增加也是推动市场成长的关键因素。微创手术比传统开放性手术有许多优势，包括疼痛更少、住院时间更短、恢復时间更快、併发症风险更低。因此，对于促进这些程序的医疗设备的需求日益增加。止血阀对于微创导管介入至关重要，因为它们可以精确控制血流并防止手术过程中洩漏。 2024 年 6 月发表在《心血管造影与介入学会杂誌》上的一篇论文讨论了经股动脉经导管主动脉瓣置换术(TAVR) 期间的止血通常是如何透过使用缝合线使用血管闭合装置 (VCD) 的预闭合技术来实现的。最近，引入了一种混合方法，当止血失败时，在移除鞘套后加入胶原蛋白塞 VCD。

由于出生率下降和医疗保健进步导致的预期寿命增加，世界人口结构正在显着地向老化转变。根据世界卫生组织（WHO）的数据，到2050年，全球60岁以上人口预计将增加一倍，达到约21亿人。这种人口结构的变化凸显了老年人中与老龄化相关的疾病（包括心血管疾病（CVD））的盛行率不断上升。根据美国心臟协会2023年11月发表的一篇论文，心臟衰竭是一种广泛而多方面的心血管疾病，影响超过670万美国，在65岁及以上的人群中尤为普遍。人口老化使得人们更容易患上心血管疾病，这推动了对诊断和治疗程序的需求，从而推动了市场成长。

医疗设备的技术进步对于推动市场成长至关重要。材料、设计和功能的创新正在带来更有效、更可靠的止血瓣膜。例如，先进的聚合物和涂层的使用使得这些装置更加耐用和生物相容性，减少了血栓症和感染疾病等併发症。此外，易于使用的锁定机制和增强的密封能力等新功能的加入提高了止血瓣在临床实践中的效率。例如，波士顿科学公司的 WATCHDOG 止血阀采用创新的十字缝设计，以最大限度地减少洩漏，并具有可同时容纳多个设备的 8F 管腔。此外，它还配有拇指托，旨在提高手术过程中的舒适度。总的来说，这些设计元素有助于降低出血和空气栓塞的风险，并在整个医疗干预过程中将患者安全放在首位。这些技术改进将使手术更加安全、高效，促进止血瓣膜的推广应用。

目录

第一章 分析方法及范围

第 2 章执行摘要

3. 止血瓣膜市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 止血阀市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • 管道分析

第四章 止血瓣膜市场：按类型估计和趋势分析

  • 全球止血阀市场：按类型分類的仪表板
  • 全球止血瓣膜市场：按类型进行差异分析
  • 全球止血瓣膜市场按类型划分（以收益为准）
  • 止血阀 Y 型连接器
  • 双Y型止血阀
  • 单手止血阀
  • 其他的

第 5 章止血瓣膜市场：按应用分類的估计和趋势分析

  • 全球止血阀市场：按应用分類的仪表板
  • 全球止血瓣膜市场：按应用的变化分析
  • 全球止血瓣膜市场按应用划分（以收益为准）
  • 血管造影术
  • 血管成形术

第六章止血瓣膜市场：按最终用途分類的估计和趋势分析

  • 全球止血阀市场：依最终用途分類的仪表板
  • 全球止血瓣膜市场：依最终用途的变化分析
  • 全球止血瓣膜市场按最终用途划分（以收益为准）
  • 医院
  • 门诊手术中心
  • 其他的

第 7 章止血瓣膜市场：区域估计和趋势分析（按国家、类型、应用和最终用途）

  • 区域控制面板
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 最新趋势和影响分析：按主要製造商
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 主要企业市场占有率分析（2024年）
  • 公司简介
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun SE
    • Terumo Corporation
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • SCW Medicath Ltd
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Nipro
    • DeRoyal Industries, Inc.
    • Antmed Corporation
    • Beijing Demax Medical Technology Co
Product Code: GVR-4-68040-342-2

Hemostasis Valve Market Size & Trends:

The global hemostasis valve market size was estimated at USD 184.6 million in 2024 and is projected to grow at a CAGR of 5.8% from 2025 to 2030. The increasing prevalence of cardiovascular diseases, supportive regulatory frameworks, rising geriatric population, and technological advancements are significantly driving the market growth. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischaemic heart disease (1.9 million deaths) and stroke (900,000 deaths). This, in turn, drives the demand for diagnostic and therapeutic procedures like angiography and angioplasty, where hemostasis valves are essential to ensure patient safety by controlling blood flow during catheterization procedures.

The growing preference for minimally invasive procedures is another significant factor propelling the market growth. Minimally invasive techniques offer numerous benefits over traditional open surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications. As a result, there is a heightened demand for medical devices that facilitate these procedures. Hemostasis valves are integral to minimally invasive catheter-based interventions, as they enable precise control of blood flow and prevent leakage during the procedure. In June 2024, an article in the Journal of the Society for Cardiovascular Angiography & Interventions discussed how hemostasis during transfemoral transcatheter aortic valve replacement (TAVR) is usually achieved with a suture-mediated vascular closure device (VCD) via a preclosure technique. Recently, a hybrid approach has been introduced, incorporating a collagen-plug VCD after sheath removal in cases where hemostasis fails.

The global demographic landscape is undergoing a notable shift towards aging, driven by declining birth rates and advancements in healthcare that have prolonged life expectancy. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion globally. This demographic transition underscores the increasing prevalence of age-related conditions, including cardiovascular diseases (CVDs) among older adults. According to the article published by the American Heart Association in November 2023, heart failure is a widespread and multifaceted cardiovascular condition impacting more than 6.7 million Americans, particularly prevalent among individuals aged 65 and older. The aging population is susceptibility to cardiovascular diseases drive the demand for diagnostic and therapeutic procedures, driving the market growth.

Technological advancements in medical devices are pivotal in driving the market growth. Materials, design, and functionality innovations have developed more effective and reliable hemostasis valves. For instance, using advanced polymers and coatings has improved the durability and biocompatibility of these devices, reducing complications such as thrombosis and infection. In addition, incorporating novel features such as easy-to-use locking mechanisms and enhanced sealing capabilities has increased the efficiency of hemostasis valves in clinical settings. For instance, the WATCHDOG Hemostasis Valve by Boston Scientific Corporation incorporates an innovative cross-slit design to minimize leakage, complemented by an 8F inner lumen that simultaneously accommodates multiple devices. In addition, it includes a thumb rest feature designed for enhanced comfort during procedures. The design elements collectively contribute to reducing blood loss and the risk of air embolism, prioritizing patient safety throughout medical interventions. These technological improvements ensure that procedures are safer and more efficient, boosting the adoption of hemostasis valves.

Global Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global hemostasis valve market report based on type, application, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Hemostasis Valve Y- Connectors
  • Double Y- Connector Hemostasis Valves
  • One- Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Angiography
  • Angioplasty
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Growing demand for minimally invasive surgeries
      • 3.2.1.3. Improved healthcare infrastructure
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of hemostasis valves
      • 3.2.2.2. Regulatory hurdles
  • 3.3. Hemostasis Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. Global Hemostasis Valve Market: Type Dashboard
  • 4.2. Global Hemostasis Valve Market: Type Movement Analysis
  • 4.3. Global Hemostasis Valve Market by Type, Revenue
  • 4.4. Hemostasis Valve Y- Connectors
    • 4.4.1. Hemostasis valve Y- connectors market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Double Y- Connector Hemostasis Valves
    • 4.5.1. Double Y- connector hemostasis valves market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. One- Handed Hemostasis Valves
    • 4.6.1. One - handed hemostasis valves market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. Global Hemostasis Valve Market: Application Dashboard
  • 5.2. Global Hemostasis Valve Market: Application Movement Analysis
  • 5.3. Global Hemostasis Valve Market by Application, Revenue
  • 5.4. Angiography
    • 5.4.1. Angiography market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Angioplasty
    • 5.5.1. Angioplasty market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Global Hemostasis Valve Market: End Use Dashboard
  • 6.2. Global Hemostasis Valve Market: End Use Movement Analysis
  • 6.3. Global Hemostasis Valve Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Hemostasis Valve Market: Regional Estimates & Trend Analysis by Country, Type, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Boston Scientific Corporation
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Teleflex Incorporated
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merit Medical Systems
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. B. Braun SE
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Terumo Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Abbott
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Argon Medical Devices
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Freudenberg Medical
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. SCW Medicath Ltd
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Lepu Medical Technology (Beijing)Co.,Ltd.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Nipro
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. DeRoyal Industries, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Antmed Corporation
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Beijing Demax Medical Technology Co
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global hemostasis valve market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 30 France hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 31 France hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 52 China hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 53 China hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 58 India hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 59 India hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Africa hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 89 UAE hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait hemostasis valve market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Hemostasis valve market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Hemostasis Valve Market: Type Outlook Key Takeaways
  • Fig. 15 Global Hemostasis Valve Market: Type Movement Analysis
  • Fig. 16 Global Hemostasis Valve Y- Connectors Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Double Y- Connector Hemostasis Valves Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global One- Handed Hemostasis Valves Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Hemostasis Valve Market: Application Outlook Key Takeaways
  • Fig. 21 Global Hemostasis Valve Market: Application Movement Analysis
  • Fig. 22 Global Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Angioplasty Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Hemostasis Valve Market: End Use Outlook Key Takeaways
  • Fig. 25 Global Hemostasis Valve Market: End Use Movement Analysis
  • Fig. 26 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Global Hemostasis Valve Market: Region Movement Analysis
  • Fig. 32 North America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia pacific Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 60 Strategy framework